|Articles|March 1, 1996

Calcium Channel Blockers: 1995 -- The Year in Review
Volume 2
Issue 4 Suppl

Calcium Channel Blockers: New Trials and Trials in Progress

Download PDF: Calcium Channel Blockers: New Trials and Trials in Progress

Articles in this issue

over 30 years ago

Article

Calcium Channel Blockers: 1995 - An Overview

over 30 years ago

Article

Safety of Calcium Channel Blockers: Results of Recent Trials

over 30 years ago

Article

Are Calcium Channel Blockers Prohemorrhagic?

over 30 years ago

Article

A Provocative Interpretation of the Case Control Analysis

over 30 years ago

Article

Update - January 1996: FDA Does Not Support Labeling Changes to Calcium Antagonists Other Than Immediate-Release Nifedipine

over 30 years ago

Article

Shades of Opinion: What Is Prudent?

over 30 years ago

Article

Participants

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Calcium Channel Blockers: New Trials and Trials in Progress

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently

Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains

Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

Defunding Co-Payment Assistance Disrupted nAMD Care

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Calcium Channel Blockers: New Trials and Trials in Progress

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently

Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains

Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

Defunding Co-Payment Assistance Disrupted nAMD Care